AAPG

Ascentage Pharma Group International (AAPG)

About Ascentage Pharma Group International (AAPG)

Ascentage Pharma Group International Co., Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.

Details

Daily high
$32.95
Daily low
$31.01
Price at open
$32.95
52 Week High
$48.45
52 Week Low
$17.00
Market cap
3.0B
Dividend yield
0.00%
Volume
3,781
Avg. volume
8,808
P/E ratio
-16.08

Ascentage Pharma Group International News

Details

Daily high
$32.95
Daily low
$31.01
Price at open
$32.95
52 Week High
$48.45
52 Week Low
$17.00
Market cap
3.0B
Dividend yield
0.00%
Volume
3,781
Avg. volume
8,808
P/E ratio
-16.08